Postural tachycardia syndrome (POTS) is characterized by symptoms of orthostatic intolerance. Antibodies of acetylcholine receptor (AChR-ab) affect acetylcholine transmission between the ganglia and result in imbalance of the autonomic nervous system in POTS. This study was designed to analyze the clinical characteristics of POTS patients with AChR-ab positive and explore the value of AChR-ab in children with POTS. In 82 children with POTS, twenty patients (24.39 %) were found as AChR-ab positive. Their clinical characteristics and hemodynamic responses to orthostatic changes were compared with the remaining 60 patients with negative AChR-ab. Symptoms of POTS children with AChR-ab positive were significantly severe than those of AChR-ab negative patients (p = 0.001). Preceding infection was predominant in patients with AChR-ab positive compared with that of patients with AChR-ab negative (p < 0.001). Syncope and fatigue were more common in the AChR-ab positive patients (p < 0.05). The change of upright heart rate was increased significantly in AChR-ab positive patients compared with AChR-ab negative cases (p = 0.013). Multiple logistic regression analysis revealed that preceding infection (OR 22.356, 95 % CI 2.151–34.920), syncope (OR 11.570, 95 % CI 2.098–63.810), and fatigue (OR 11.145, 95 % CI 1.658–74.911) were independent risk factors for POTS with AChR-ab positive. In conclusion, POTS with positive AChR-ab was a heterogeneous disorder. Preceding infection, syncope and fatigue were their main clinical characteristics.
This is a preview of subscription content, log in to check access.
This work was supported by grants from the Beijing Committee of Science and Technology, China (Z121107001012051) and the National Twelfth 5-Year Plan for Science and Technology Support (2012BAI03B03).
Conflict of interest
The authors declare that they have no conflicts of interest.
Chinese Pediatric Cardiology Society, Editorial Board of Chinese Journal of Pediatrics (2009) Guideline of diagnosis of syncope in children. Zhonghua Er Ke Za Zhi 47:99–100Google Scholar
Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I et al (2009) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69–72CrossRefGoogle Scholar
Gibbons CH, Freeman R (2009) Antibody titers predict clinical features of autoimmune autonomic ganglionopathy. Auton Neurosci 146:8–12PubMedCrossRefGoogle Scholar
Grubb BP, Kanjwal Y, Kosinski DJ (2006) The postural tachycardia syndrome: a concise guide to diagnosis and management. J Cardiovasc Electrophysiol 17:108–112PubMedGoogle Scholar
Ishitobi M, Haginoya K, Kitamura T, Munakata M, Yokoyama H, Iinuma K (2004) Acute dysautonomia: Complete recovery after two courses of IVIG. Brain Dev 26:542–544PubMedCrossRefGoogle Scholar
Kanjwal Y, Kosinski D, Grubb BP (2003) The postural orthostatic tachycardia syndrome definitions, diagnosis, and management. Pacing Clin Electrophysiol 26:1747–1757PubMedCrossRefGoogle Scholar
Kanjwal K, Karabin B, Sheikh M, Elmer L, Kanjwal Y, Saeed B et al (2011) Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience. Pacing Clin Electrophysiol 34:750–755PubMedCrossRefGoogle Scholar
Oldstone MB (2005) Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Curr Top Microbiol Immunol 296:1–17PubMedGoogle Scholar
Raj SR, Black BK, Biaggioni I, Harris PA, Robertson D (2005) Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 111:2734–2740PubMedCrossRefGoogle Scholar
Singer W, Sletten DM, Opfer-Gehrking TL, Brands CK, Fischer PR, Low PA (2012) Postural tachycardia in children and adolescents: what is abnormal? J Pediatr 160:222–226PubMedCentralPubMedCrossRefGoogle Scholar
Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson LM, Fealey RD, Vernino S et al (2007) Postural orthostatic tachycardia syndrome: the mayo clinic experience. Mayo Clin Proc 82:308–313PubMedCrossRefGoogle Scholar
Tüzün E, Christadoss P (2013) Complement associated pathogenic mechanisms in myasthenia gravis. Autoimmun Rev 12:904–911PubMedCrossRefGoogle Scholar
Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA, Muscle Study Group (2008) Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol 197:63–69PubMedCentralPubMedCrossRefGoogle Scholar
Wang Z, Low PA, Jordan J, Freeman R, Gibbons CH, Schroeder C et al (2007) Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology 68:1917–1921PubMedCentralPubMedCrossRefGoogle Scholar
Wang XL, Ling TY, Charlesworth MC, Figueroa JJ, Low P, Shen WK et al (2013) Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome. Transl Res 162:34–44PubMedCentralPubMedCrossRefGoogle Scholar
Winker R, Barth A, Dorner W, Mayr O, Pilger A, Ivancsits S et al (2003) Diagnostic management of orthostatic intolerance in the workplace. Int Arch Occup Environ Health 76:143–150PubMedGoogle Scholar
Zhang F, Li X, Ochs T, Chen L, Liao Y, Tang C et al (2012) Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. J Am Coll Cardiol 60:315–320PubMedCrossRefGoogle Scholar
Zhang Q, Liao Y, Tang C, Du J, Jin H (2012) Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome. J Pediatr 161:281–284PubMedCrossRefGoogle Scholar